531335 Stock Overview Engages in the development, production, marketing, and distribution of health and wellness products in India. More details
Rewards Risk Analysis See All Risk Checks Capture your thoughts, links and company narrative
Add noteZydus Wellness Limited Competitors Price History & Performance
Summary of share price highs, lows and changes for Zydus Wellness Historical stock prices Current Share Price ₹1,911.45 52 Week High ₹2,484.00 52 Week Low ₹1,441.75 Beta 0.077 1 Month Change -1.58% 3 Month Change -8.21% 1 Year Change 20.15% 3 Year Change 2.15% 5 Year Change 29.87% Change since IPO 18,639.71%
Recent News & Updates
Zydus Wellness Limited (BSE:531335) completed the acquisition of Naturell India Private Limited for INR 3.9 billion. Dec 03
Second quarter 2025 earnings released: EPS: ₹3.28 (vs ₹0.93 in 2Q 2024) Nov 12
Zydus Wellness Limited (BSE:531335) signed a letter of intent to acquire Naturell India Private Limited for INR 3.9 billion. Oct 31
Zydus Wellness Limited Announces Executive Appointments Oct 15
Zydus Wellness Limited Announces Resignation of Ashish P. Bhargava as Nominee Director Oct 01
Zydus Wellness Limited Approves Final Dividend for the Financial Year Ended March 31, 2024 Aug 22 See more updates
Zydus Wellness Limited (BSE:531335) completed the acquisition of Naturell India Private Limited for INR 3.9 billion. Dec 03
Second quarter 2025 earnings released: EPS: ₹3.28 (vs ₹0.93 in 2Q 2024) Nov 12
Zydus Wellness Limited (BSE:531335) signed a letter of intent to acquire Naturell India Private Limited for INR 3.9 billion. Oct 31
Zydus Wellness Limited Announces Executive Appointments Oct 15
Zydus Wellness Limited Announces Resignation of Ashish P. Bhargava as Nominee Director Oct 01
Zydus Wellness Limited Approves Final Dividend for the Financial Year Ended March 31, 2024 Aug 22
Price target increased by 15% to ₹2,160 Aug 04
Full year 2024 earnings: EPS misses analyst expectations Jul 12 Zydus Wellness Limited to Report Q3, 2025 Results on Feb 14, 2025
Investor sentiment improves as stock rises 17% Jul 05
Price target increased by 8.2% to ₹1,883 May 16
Dividend of ₹5.00 announced May 16
Zydus Wellness Limited, Annual General Meeting, Aug 02, 2024 May 16
Full year 2024 earnings: EPS misses analyst expectations May 15
Zydus Wellness Limited Recommends Final Dividend, Payable on or After August 7, 2024 May 15
Zydus Wellness Limited to Report Q4, 2024 Results on May 14, 2024 May 07
Insider recently bought ₹175m worth of stock Feb 27
Consensus EPS estimates fall by 15% Feb 15
Third quarter 2024 earnings released: EPS: ₹0.05 (vs ₹3.07 in 3Q 2023) Feb 09
Zydus Wellness Limited to Report Q3, 2024 Results on Feb 08, 2024 Jan 29
Second quarter 2024 earnings released: EPS: ₹0.93 (vs ₹1.33 in 2Q 2023) Nov 07
Zydus Wellness Limited Announces Resignation of Savyasachi Sengupta as Independent Director Nov 02
Zydus Wellness Limited to Report Q2, 2024 Results on Nov 06, 2023 Oct 28
Insider recently bought ₹331m worth of stock Aug 21
Zydus Wellness Limited Approves Final Dividend for the Financial Year Ended March 31, 2023 Aug 04
New minor risk - Dividend sustainability Aug 03
Zydus Wellness Limited to Report Q1, 2024 Results on Aug 03, 2023 Jul 25
Upcoming dividend of ₹5.00 per share at 0.3% yield Jul 14
Full year 2023 earnings: EPS misses analyst expectations Jul 12
Insider recently bought ₹385m worth of stock Jun 29
Insider recently bought ₹148m worth of stock Jun 13
Price target decreased by 7.4% to ₹1,813 Jun 05
Zydus Wellness Limited, Annual General Meeting, Aug 03, 2023 May 19 Zydus Wellness Limited Appoints Akhil Monappa as Additional Director (Non Executive & Independent Director)
Full year 2023 earnings: EPS misses analyst expectations May 18
Zydus Wellness Limited, Annual General Meeting, Aug 03, 2023 May 17
Insider recently bought ₹1.8m worth of stock Mar 02
Third quarter 2023 earnings released: EPS: ₹3.07 (vs ₹3.66 in 3Q 2022) Feb 04
CEO & Whole Time Director recently bought ₹301k worth of stock Dec 31
Second quarter 2023 earnings released: EPS: ₹1.33 (vs ₹3.37 in 2Q 2022) Nov 16
Insider recently bought ₹16m worth of stock Sep 18
Insider recently bought ₹9.2m worth of stock Sep 01
Zydus Wellness Limited Declares Final Dividend for the Financial Year Ended March 31, 2022 Jul 30 Zydus Wellness Limited Appoints Nandish P. Joshi as the Company Secretary Jul 29
Upcoming dividend of ₹5.00 per share Jul 07 Zydus Wellness Limited to Report First Half, 2023 Results on Nov 14, 2022
Insider recently bought ₹55m worth of stock May 28
Full year 2022 earnings: Revenues and EPS in line with analyst expectations May 21
Zydus Wellness Limited Recommends Final Dividend for the Year Ended on March 31, 2022, Payable on or After August 4, 2022 May 18
Consensus forecasts updated May 18 Zydus Wellness Limited, Annual General Meeting, Jul 29, 2022
Price target decreased to ₹2,125 Apr 27
Insufficient new directors Apr 27
Price target decreased to ₹2,125 Apr 12
Insufficient new directors Apr 02
Insider recently bought ₹757k worth of stock Feb 17
Zydus Wellness Limited Announces Resignation of Dhanraj P. Dagar as Company Secretary & Compliance Officer, Effective May 10, 2022 Feb 16
Consensus EPS estimates fall by 10% Feb 09
Price target decreased to ₹2,339 Feb 08
Third quarter 2022 earnings: EPS exceeds analyst expectations while revenues lag behind Feb 03
CEO & Whole Time Director recently bought ₹812k worth of stock Nov 14
Second quarter 2022 earnings released: EPS ₹3.37 (vs ₹18.14 loss in 2Q 2021) Oct 30
Insider recently sold ₹2.3m worth of stock Aug 28
Price target increased to ₹2,517 Jul 18
Upcoming dividend of ₹5.00 per share Jul 07
Full year 2021 earnings released: EPS ₹19.55 (vs ₹24.58 in FY 2020) Jul 06
Full year 2021 earnings released: EPS ₹19.55 (vs ₹24.58 in FY 2020) May 12
Zydus Wellness Limited Recommends Final Dividend May 11
Price target raised to ₹2,266 Feb 10
Third quarter 2021 earnings released: EPS ₹0.27 (vs ₹0.73 in 3Q 2020) Feb 02
Revenue beats expectations, earnings disappoint Feb 02
Zydus Announces United States Food and Drug Administration (USFDA) Has Granted `Orphan Drug Designation' (ODD) to Saroglitazar Mg for the Treatment of Patients with Primary Biliary Cholangitis Jan 29
Zydus Wellness Limited to Report Q3, 2021 Results on Feb 01, 2021 Jan 25
New 90-day high: ₹1,940 Dec 24
New 90-day high: ₹1,919 Dec 09
Price target raised to ₹2,039 Nov 25
Second quarter 2021 earnings released: ₹18.14 loss per share Nov 03
Revenue and earnings miss expectations Nov 03
Price target raised to ₹1,877 Oct 14
Zydus Wellness Limited has completed a Follow-on Equity Offering in the amount of INR 6.49974 billion. Sep 30
Zydus Wellness Limited announced a financing transaction Aug 27
Zydus Wellness Limited to Report Q1, 2021 Results on Jul 31, 2020 Jul 21
Zydus Wellness Limited Provides Operational Update Jul 17 Shareholder Returns 531335 IN Food IN Market 7D -5.2% -1.8% -2.1% 1Y 20.2% 3.4% 22.5%
See full shareholder returns
Return vs Industry: 531335 exceeded the Indian Food industry which returned 3.4% over the past year.
Return vs Market: 531335 underperformed the Indian Market which returned 22.5% over the past year.
Price Volatility Is 531335's price volatile compared to industry and market? 531335 volatility 531335 Average Weekly Movement 4.1% Food Industry Average Movement 6.1% Market Average Movement 6.2% 10% most volatile stocks in IN Market 9.1% 10% least volatile stocks in IN Market 4.1%
Stable Share Price: 531335 has not had significant price volatility in the past 3 months compared to the Indian market.
Volatility Over Time: 531335's weekly volatility (4%) has been stable over the past year.
About the Company Zydus Wellness Limited engages in the development, production, marketing, and distribution of health and wellness products in India. It provides sugar substitute products under the Sugar Free Gold, Sugar Free Natura, and Sugar Free Green brands; milk-based health food drink under the Complan brand; glucose-based beverage under the Glucon-D brand; and I’m lite a blended sugar coated with stevia. The company offers a range of skincare products, such as soap-free face washes, face masks, scrubs, and leave-on-products under the Everyuth brand; prickly heat and cooling powder, and hand sanitizer under the Nycil brand; and probiotic butter spread, table spread, ghee, butter, cholesterol fat-free spread, mayonnaise, and chocolate spread under the Nutralite brand.
Show more Zydus Wellness Limited Fundamentals Summary How do Zydus Wellness's earnings and revenue compare to its market cap? 531335 fundamental statistics Market cap ₹121.63b Earnings (TTM ) ₹3.19b Revenue (TTM ) ₹25.20b
Earnings & Revenue Key profitability statistics from the latest earnings report (TTM) 531335 income statement (TTM ) Revenue ₹25.20b Cost of Revenue ₹12.11b Gross Profit ₹13.09b Other Expenses ₹9.90b Earnings ₹3.19b
Last Reported Earnings
Sep 30, 2024
Next Earnings Date
Feb 14, 2025
Earnings per share (EPS) 50.16 Gross Margin 51.96% Net Profit Margin 12.67% Debt/Equity Ratio 2.7%
How did 531335 perform over the long term?
See historical performance and comparison Dividends
0.3% Current Dividend Yield
Company Analysis and Financial Data Status Data Last Updated (UTC time) Company Analysis 2024/12/20 01:04 End of Day Share Price 2024/12/20 00:00 Earnings 2024/09/30 Annual Earnings 2024/03/31
Data Sources The data used in our company analysis is from S&P Global Market Intelligence LLC . The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
Package Data Timeframe Example US Source * Company Financials 10 years Income statement Cash flow statement Balance sheet Analyst Consensus Estimates +3 years Forecast financials Analyst price targets Market Prices 30 years Stock prices Dividends, Splits and Actions Ownership 10 years Top shareholders Insider trading Management 10 years Leadership team Board of directors Key Developments 10 years
* example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here .
Analysis Model and Snowflake Details of the analysis model used to generate this report is available on our Github page , we also have guides on how to use our reports and tutorials on Youtube .
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .
Analyst Sources Zydus Wellness Limited is covered by 14 analysts. 6 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
Analyst Institution Ajay Thakur Anand Rathi Shares and Stock Brokers Limited null null Asian Markets Securities Private Limited Tejash Shah Avendus Spark
Show 11 more analysts